Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus

被引:127
作者
Marcusson, EG [1 ]
Bhat, B [1 ]
Manoharan, M [1 ]
Bennett, CF [1 ]
Dean, NM [1 ]
机构
[1] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1093/nar/26.8.2016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligonucleotides complementary to specific mRNA sequences are widely used inhibitors of gene expression in vitro and in vivo. In vitro cationic lipids have been demonstrated to increase the pharmacological activity of antisense oligonucleotides by increasing cellular uptake and facilitating nuclear accumulation. We have investigated the intracellular fate of oligonucleotide/cationic lipid complexes using fluorescently labeled lipids and oligonucleotides targeted to protein kinase C-alpha. After addition to cells the lipids initially co-localized with the oligonucleotide on the cell surface and in fine punctate structures within the cytoplasm. At later times the oligonucleotide began to accumulate in the nucleus as well as the cytoplasm. In contrast, the cationic lipid remained localized to the cell surface and the cytoplasm and was never found in the nucleus. Expression of protein kinase C-alpha mRNA did not begin to decline until after oligonucleotide was seen in the nucleus. This was also coincident with the transient appearance of a smaller mRNA transcript believed to result from RNase H cleavage of protein kinase C-alpha mRNA. These data suggest that although cationic lipids facilitate uptake of oligonucleotides, the complex must disassociate before the oligonucleotide can gain access to the nucleus and induce degradation of targeted mRNA.
引用
收藏
页码:2016 / 2023
页数:8
相关论文
共 58 条
[31]   Biological Activity of Oligonucleotide-Poly(L-lysine) Conjugates: Mechanism of Cell Uptake [J].
Leonetti, Jean-Paul ;
Degols, Genevieve ;
Lebleu, Bernard .
BIOCONJUGATE CHEMISTRY, 1990, 1 (02) :149-153
[32]   INTRACELLULAR-DISTRIBUTION OF MICROINJECTED ANTISENSE OLIGONUCLEOTIDES [J].
LEONETTI, JP ;
MECHTI, N ;
DEGOLS, G ;
GAGNOR, C ;
LEBLEU, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2702-2706
[33]   A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA [J].
Lewis, JG ;
Lin, KY ;
Kothavale, A ;
Flanagan, WM ;
Matteucci, MD ;
DePrince, RB ;
Mook, RA ;
Hendren, RW ;
Wagner, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3176-3181
[34]   CHARACTERIZATION OF OLIGONUCLEOTIDE TRANSPORT INTO LIVING CELLS [J].
LOKE, SL ;
STEIN, CA ;
ZHANG, XH ;
MORI, K ;
NAKANISHI, M ;
SUBASINGHE, C ;
COHEN, JS ;
NECKERS, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3474-3478
[35]   Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes [J].
Ma, DDF ;
Wei, AQ .
LEUKEMIA RESEARCH, 1996, 20 (11-12) :925-930
[36]  
MONIA BP, 1992, J BIOL CHEM, V267, P19954
[37]  
Nakai D, 1996, J PHARMACOL EXP THER, V278, P1362
[38]   THE THERAPEUTIC POTENTIAL OF ANTISENSE OLIGONUCLEOTIDES [J].
SHARMA, HW ;
NARAYANAN, R .
BIOESSAYS, 1995, 17 (12) :1055-1063
[39]   ANTISENSE C-MYB OLIGONUCLEOTIDES INHIBIT INTIMAL ARTERIAL SMOOTH-MUSCLE CELL ACCUMULATION INVIVO [J].
SIMONS, M ;
EDELMAN, ER ;
DEKEYSER, JL ;
LANGER, R ;
ROSENBERG, RD .
NATURE, 1992, 359 (6390) :67-70
[40]  
SPILLER DG, 1992, ANTI-CANCER DRUG DES, V7, P115